For: | Malaguarnera G, Giordano M, Paladina I, Rando A, Uccello M, Basile F, Biondi A, Carnazzo S, Alessandria I, Mazzarino C. Markers of bile duct tumors. World J Gastrointest Oncol 2011; 3(4): 49-59 [PMID: 21528090 DOI: 10.4251/wjgo.v3.i4.49] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v3/i4/49.htm |
Number | Citing Articles |
1 |
Hafida Benhammane, Saoussane Kharmoum, Sylvain Terraz, Thierry Berney, Thai Nguyen-Tang, Muriel Genevay, Omar El Mesbahi, Arnaud Roth. Common bile duct adenocarcinoma in a patient with situs inversus totalis: report of a rare case. BMC Research Notes 2012; 5(1) doi: 10.1186/1756-0500-5-681
|
2 |
Ling Cheng, Ping-hua Xu, Bao-de Shen, Gang Shen, Juan-juan Li, Ling Qiu, Chao-yong Liu, Hai-long Yuan, Jin Han. Improve bile duct-targeted drug delivery and therapeutic efficacy for cholangiocarcinoma by cucurbitacin B loaded phospholipid complex modified with berberine hydrochloride. International Journal of Pharmaceutics 2015; 489(1-2): 148 doi: 10.1016/j.ijpharm.2015.04.024
|
3 |
Wipaporn JARUJAREET, Kensuke TAIRA, Hong Kean OOI. Dynamics of liver enzymes in rabbits experimentally infected with <i>Fasciola</i> sp. (Intermediate form from Japan). Journal of Veterinary Medical Science 2018; 80(1): 36 doi: 10.1292/jvms.17-0315
|
4 |
Krishan R. Jethwa, Christopher L. Hallemeier. Principles and Practice of Particle Therapy. 2022; : 311 doi: 10.1002/9781119707530.ch19
|
5 |
Michelle X. Yang, Ryan F. Coates, Abiy Ambaye, Juli-Anne Gardner, Richard Zubarick, Yuan Gao, Joan Skelly, James G. Liu, Mari Mino-Kenudson. Investigation of HNF-1B as a diagnostic biomarker for pancreatic ductal adenocarcinoma. Biomarker Research 2018; 6(1) doi: 10.1186/s40364-018-0139-6
|
6 |
Ge Zhang, Shuai Gong, Lina Pang, Lixia Hou, Wei He. Efficacy and Safety of Apatinib Treatment for Advanced Cholangiocarcinoma After Failed Gemcitabine-Based Chemotherapy: An Open-Label Phase II Prospective Study. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.659217
|
7 |
Eduardo E. Montalvo-Javé, Germán E. Mendoza Barrera, Alan I. Valderrama Treviño, María C. Piña Barba, César Montalvo-Arenas, Fernando Rojas Mendoza, Benjamin León Mancilla, Manuel A. García Pineda, Álvaro Jaime Limón, Jorge Albores Saavedra, Jesús Tapia-Jurado. Absorbable bioprosthesis for the treatment of bile duct injury in an experimental model. International Journal of Surgery 2015; 20: 163 doi: 10.1016/j.ijsu.2015.06.074
|
8 |
Wiphawan Wasenang, Ponlatham Chaiyarit, Siriporn Proungvitaya, Temduang Limpaiboon. Serum cell-free DNA methylation of OPCML and HOXD9 as a biomarker that may aid in differential diagnosis between cholangiocarcinoma and other biliary diseases. Clinical Epigenetics 2019; 11(1) doi: 10.1186/s13148-019-0634-0
|
9 |
Antonio Biondi, Giulia Malaguarnera, Marco Vacante, Massimiliano Berretta, Velia D’Agata, Michele Malaguarnera, Francesco Basile, Filippo Drago, Gaetano Bertino. Elevated serum levels of Chromogranin A in hepatocellular carcinoma. BMC Surgery 2012; 12(S1) doi: 10.1186/1471-2482-12-S1-S7
|
10 |
Chao Yin, Monika Kulasekaran, Tina Roy, Brennan Decker, Sonja Alexander, Mathew Margolis, Reena C. Jha, Gary M. Kupfer, Aiwu R. He. Homologous Recombination Repair in Biliary Tract Cancers: A Prime Target for PARP Inhibition?. Cancers 2022; 14(10): 2561 doi: 10.3390/cancers14102561
|
11 |
Mario Uccello, Giulia Malaguarnera, Thea Corriere, Antonio Biondi, Francesco Basile, Mariano Malaguarnera. Risk of Hepatocellular Carcinoma in Workers Exposed to Chemicals. Hepatitis Monthly 2012; 12(10) doi: 10.5812/hepatmon.5943
|
12 |
Michael T. Schmidt, Eric A. Himmelfarb, Hedyeh Shafi, Fan Lin, Haodong Xu, Hanlin L. Wang. Use of IMP3, S100P, and pVHL Immunopanel to Aid in the Interpretation of Bile Duct Biopsies With Atypical Histology or Suspicious for Malignancy. Applied Immunohistochemistry & Molecular Morphology 2012; 20(5): 478 doi: 10.1097/PAI.0b013e318245e05b
|
13 |
Liting Wang, Jiwen Wang, Ke Gong, Qing Shen, Hao Fu, Hui Huang, Chuanrong Chen, Lin Zhang, Yourong Duan, Tao Suo. Amyloid Precursor Protein Influences Gallbladder Cancer Cell Behaviors and may be an Effective Prognostic Factor. Nano LIFE 2020; 10(01n02): 2040002 doi: 10.1142/S1793984420400024
|
14 |
Patutong Chatchawal, Molin Wongwattanakul, Patcharaporn Tippayawat, Nichada Jearanaikoon, Amonrat Jumniansong, Thidarat Boonmars, Patcharee Jearanaikoon, Bayden R. Wood. Monitoring the Progression of Liver Fluke-Induced Cholangiocarcinoma in a Hamster Model Using Synchrotron FTIR Microspectroscopy and Focal Plane Array Infrared Imaging. Analytical Chemistry 2020; 92(23): 15361 doi: 10.1021/acs.analchem.0c02656
|
15 |
M. Grunnet, I.J. Christensen, U. Lassen, L.H. Jensen, M. Lydolph, I.K. Lund, T. Thurison, G. Høyer-Hansen, M. Mau-Sørensen. Prognostic significance of circulating intact and cleaved forms of urokinase plasminogen activator receptor in inoperable chemotherapy treated cholangiocarcinoma patients. Clinical Biochemistry 2014; 47(7-8): 599 doi: 10.1016/j.clinbiochem.2014.01.030
|
16 |
Erfan Amini, Farhad Pishgar, Asal Hojjat, Mohammad Soleimani, Majid Ali Asgari, Abdol-Mohammad Kajbafzadeh. The role of serum and urinary carbohydrate antigen 19-9 in predicting renal injury associated with ureteral stone. Renal Failure 2016; 38(10): 1626 doi: 10.1080/0886022X.2016.1202732
|
17 |
Aleksandra Lasota, Anna Wasilewska, Agnieszka Rybi-Szumińska. Current Status of Protein Biomarkers in Urolithiasis—A Review of the Recent Literature. Journal of Clinical Medicine 2023; 12(22): 7135 doi: 10.3390/jcm12227135
|
18 |
Razieh Sangsari, Kayvan Mirnia, Maryam Saeedi, Nina Gozali Asl, Abdol-Mohammad Kajbafzadeh. Prognostic Value of Carbohydrate Antigen 19-9 in the Urine of Mothers with Fetal Hydronephrosis to the Severity and Cause of Neonatal Renal Involvement. Journal of Clinical Neonatology 2022; 11(3): 143 doi: 10.4103/jcn.jcn_6_22
|
19 |
Patricia García, Carolina Bizama, Lorena Rosa, Jaime A. Espinoza, Helga Weber, Javier Cerda-Infante, Marianela Sánchez, Viviana P. Montecinos, Justo Lorenzo-Bermejo, Felix Boekstegers, Marcela Dávila-López, Francisca Alfaro, Claudia Leiva-Acevedo, Zasha Parra, Diego Romero, Sumie Kato, Pamela Leal, Marcela Lagos, Juan Carlos Roa. Functional and genomic characterization of three novel cell lines derived from a metastatic gallbladder cancer tumor. Biological Research 2020; 53(1) doi: 10.1186/s40659-020-00282-7
|
20 |
Changpeng Chai, Huan Tang, Xin Miao, Tingting Chen, Yuanhui Su, Lu Li, Long Miao, Bo Zhang, Zhengfeng Wang, Wei Luo, Hui Zhang, Hao Xu, Wence Zhou. Establishment and characterization of a novel human gallbladder cancer cell line, GBC-X1. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-72830-0
|
21 |
Kensuke Terai, Meizi Jiang, Wataru Tokuyama, Takeyoshi Murano, Nobuo Takada, Kengo Fujimura, Hiroyuki Ebinuma, Toshihiko Kishimoto, Nobuyuki Hiruta, Wolfgang J. Schneider, Hideaki Bujo. Levels of soluble LR11/SorLA are highly increased in the bile of patients with biliary tract and pancreatic cancers. Clinica Chimica Acta 2016; 457: 130 doi: 10.1016/j.cca.2016.04.010
|
22 |
Iago Dillion Lima Cavalcanti, José Cleberson Santos Soares. Advances in Cancer Treatment. 2021; : 15 doi: 10.1007/978-3-030-68334-4_3
|
23 |
Eric I Marks, Matthew Brennan, Wafik S El-Deiry. Correlation of CEA but not CA 19-9 as serum biomarkers of disease activity in a case of metastatic rectal adenocarcinoma. Cancer Biology & Therapy 2015; 16(8): 1136 doi: 10.1080/15384047.2015.1057360
|
24 |
Giuliana Cavalloni, Caterina Peraldo-Neia, Chiara Varamo, Laura Casorzo, Carmine Dell’Aglio, Paola Bernabei, Giovanna Chiorino, Massimo Aglietta, Francesco Leone. Establishment and characterization of a human intrahepatic cholangiocarcinoma cell line derived from an Italian patient. Tumor Biology 2016; 37(3): 4041 doi: 10.1007/s13277-015-4215-3
|
25 |
|
26 |
Marian A. Taulescu, Pompei F. Bolfă, Rareş Buiga, Adrian F. Gal, Bogdan Sevastre, Iancu Morar, Cornel Cătoi. Metastatic cholangiocarcinoma in a llama (Lama glama). Journal of Veterinary Diagnostic Investigation 2012; 24(5): 986 doi: 10.1177/1040638712452110
|